The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2020
Filed:
Oct. 27, 2017
Applicant:
Chase Pharmaceuticals Corporation, Parsippany, NJ (US);
Inventors:
Kathleen E. Clarence-Smith, Washington, DC (US);
Thomas N. Chase, Washington, DC (US);
Assignee:
Chase Pharmaceuticals Corporation, Parsippany, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/435 (2006.01); A61K 31/13 (2006.01); A61K 31/473 (2006.01); A61K 31/445 (2006.01); A61K 31/4725 (2006.01); A61K 31/496 (2006.01);
U.S. Cl.
CPC ...
A61K 31/13 (2013.01); A61K 31/445 (2013.01); A61K 31/473 (2013.01); A61K 31/4725 (2013.01); A61K 31/496 (2013.01); A61K 2300/00 (2013.01);
Abstract
A pharmaceutical combination of memantine and a non-anticholinergic antiemetic agent for the treatment of hypocholinergic disorders in further combination with high doses of donepezil and with solifenacin, and kits comprising said combination. A pharmaceutical combination of memantine and solifenacin for the treatment of hypocholinergic disorders, including Alzheimer type dementia, in further combination with high doses of donepezil, and kits comprising said combination.